Detailed Programme

Legend

Symposia, Special Sessions, Plenary Session, Meet The Expert, Meet the Editors, Poster Spotlights
Industry sponsored Symposium, Industry Spotlights
Networking, Career Discovery Sessions, Poster Sessions

Sunday, 15 June 2025 - Early Career Symposium

Time Session
14:00
15:40
(Separate pre-registration required)
  • 14:00
    Welcome Message
    CaffarelMaria M. Chair Spain
  • 14:10
    FAK Inhibition Promotes Critical Cytotoxic Interactions Between CD8 T Cells and Cancer Cells in Metastatic Breast Cancer
    BarthNicole Speaker United Kingdom
  • 14:40
    Proffered Paper 1: Inhibition of Furin in CAR macrophages directs them toward a proinflammatory phenotype and enhances their antitumor activities
    ZIANE CHAOUCHE Lydia Presenter France
  • 14:55
    Proffered Paper 2: Multimodal analysis of spatial transcriptomics data uncovers novel invasive lobular carcinoma subtypes
    SerraMatteo Presenter Belgium
  • 15:10
    Targeting cytokine signalling to block cancer-promoting inflammation and tumour progression
    CaffarelMaria M. Speaker Spain
Auditorium VIII
15:40
16:10
Refreshment Break
16:10
17:40
(Separate pre-registration required)
TichetMelanie Chair Switzerland
  • 16:10
    Reprogramming immunosuppressive tumor-associated macrophages potentiates standard-of-care therapy in melanoma
    TichetMelanie Speaker Switzerland
  • 16:40
    Proffered Paper 3: SoxC transcription factors are oncoembryonic regulators of colon development and cancer
    DalessiTosca Presenter Switzerland
  • 16:55
    Proffered Paper 4: Erythrocyte-derived sphingosine-1-phosphate promotes tumor cell survival in the circulation
    VuceticAdriana Presenter Germany
  • 17:10
    Therapeutic OVERactivation of oncogenic signaling as a cancer treatment strategy
    dos Santos DiasMatheus Speaker The Netherlands
Auditorium VIII
17:40
18:30
Meet the ECR Council - Panel Discussion
(Separate pre-registration required)
Auditorium VIII
18:30
20:00
Early Career Networking Reception
(Separate pre-registration required)
Main Foyer

Monday, 16 June 2025

Time Session
08:15
14:00
Women in Leadership
(Separate pre-registration required)
Offsite Venue
08:30
10:00
(Separate pre-registration required)
MorandiAndrea Chair Italy
  • 08:30
    Exploiting metabolic vulnerabilities to improve breast cancer therapy
    MorandiAndrea Speaker Italy
  • 09:00
    Proffered Paper 5: Melting the Iceberg: Nanomedicines Overcoming Stromal Barriers and Recruiting Effector T Cells in Pancreatic Cancer
    AcúrcioCRita Presenter Portugal
  • 09:15
    Proffered Paper 6: ENO3PEP vaccine enhances chemotherapy efficacy in pancreatic cancer by boosting anti-tumor immunity
    BrugiapagliaSilvia Presenter Italy
  • 09:30
    Stem cells-based models of tumor initiation and metastasis
    BaggioliniArianna Speaker Switzerland
  • 10:00
    Refreshment Break
Auditorium VIII
10:20
12:00
BardelliAlberto Co-Chair Italy
JerónimoCarmen Co-Chair Portugal
  • 10:20
    γδ T Cells in Cancer and Cancer Immunotherapy
    SantosBruno Silva Speaker Portugal
  • 10:40
    Zebrafish Cancer Avatars for Clinical Decision-making
    FiorRita Speaker Portugal
  • 11:00
    IL-7 and IL-7R: Subverting Lymphoid Development Towards Leukemia
    BarataJoão T. Speaker Portugal
  • 11:20
    Association Between CDH1 Germline Variants and Cancer Phenotypes
    OliveiraCarla Speaker Portugal
  • 11:40
    Questions & Answers
Auditorium VI+VII
10:30
12:00
(Separate pre-registration required)
JacquemetGuillaume Chair Finland
  • 10:30
    Attaching to and Crossing Endothelial Barriers
    JacquemetGuillaume Speaker Finland
  • 11:00
    Proffered Paper 7: CD24-mediated differential platelets-tumor cells binding tunes metastatic progression
    LiboniCristina Presenter France
  • 11:15
    Proffered Paper 8: Microfluidic Single-Cell Profiling in Prostate Cancer Bone Metastasis Reveals Ultra-Migratory Subpopulations, Tumour-Bone Crosstalk and CTC Heterogeneity.
    CottonThomasDaniele Presenter United Kingdom
  • 11:30
    Dissecting the immune-related signaling networks promoting breast cancer progression
    CohenMerav Speaker Israel
Auditorium VIII
GalligioniEnzo Moderator Italy
BishRebecca Moderator United States
  • 10:30
    Immune Conversations in Cancer—and Why Every Voice Counts
    The Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award 2025
    de VisserKarin E. Speaker Netherlands
  • 10:45
    Lessons from Senescence: Using our model systems as a guide to life
    EACR-Mark Foundation-Pezcoller Foundation Rising Star Award 2025
    KovatchevaMarta Speaker Italy
  • 11:00
    Title to be announced
    The Pezcoller Foundation-EACR Translational Cancer Researcher Award 2025
    AmitIdo Speaker Israel
  • 11:15
    Discussion with the Experts
Career Discovery Area
12:00
14:00
Lunch Break / Exhibition
Main Foyer
12:15
13:00
CharlesworthTom Industry Moderator/ Chair United Kingdom
  • 12:15
    Introduction
    CharlesworthTom Industry Moderator/ Chair United Kingdom
  • 12:25
    Unlocking Hidden Signals: A multimodal approach to ctDNA detection in early prostate cancer
    SadeghiHanieh Industry Speaker Austria
  • 12:40
    Characterisation of Advanced BC Subtypes in cfDNA by methylation profiling
    CuttsRos Industry Speaker United Kingdom
Auditorium VI+VII
SheehyKevin Industry Moderator/ Chair United States
  • 12:15
    Introduction
    SheehyKevin Industry Moderator/ Chair United States
  • 12:20
    Industry-Leading Spatial Solutions for High-Plex Multiomic Tissue Exploration and Discovery
    KoenigChristoph Industry Speaker Germany
  • 12:30
    Streamlining Next-Gen Spatial Proteomics with EpicIF™ Technology and the PowerOMX™ Engine
    BraubachOliver Industry Speaker United States
  • 12:40
    Sub-cellular, multiomic imaging of the entire protein-coding transcriptome (18936-plex RNA) and 75-plex Protein on a single-slide FFPE tissue section using CosMx Spatial Molecular Imaging
    LyssandJohnny Industry Speaker United States
Auditorium VIII
13:15
14:00
MayClaudia Industry Moderator/ Chair United States
  • 13:15
    Introduction
    MayClaudia Industry Moderator/ Chair United States
  • 13:20
    Spatial immune landscape of cutaneous squamous cell carcinomas (cSCC) prior to immune checkpoint blockade
    ReschkeRobin Industry Speaker Germany
  • 13:40
    Improving Immunotherapy Strategies Through Single-Cell Profiling of Lung Cancer
    BischofPhilip Industry Speaker Germany
Auditorium VI+VII
Roberto Spada Industry Moderator/ Chair
  • 13:15
    Introduction
    Roberto Spada Industry Moderator/ Chair
  • 13:25
    Spatial Predictors of Immunotherapy Response in Triple-Negative Breast Cancer
    GiampaoloBianchini Industry Speaker Italy
Auditorium VIII
14:00
15:15
CarracedoArkaitz Co-Chair Spain
SalvadorBeatriz Co-Chair United Kingdom
  • 14:00
    Proffered Paper: IL-1R8 acts as an immune checkpoint in CD8+ T cells, limiting cytokine-induced anti-tumor immune responses
    EACR25-1517
    GarutiRoberto Presenter Italy
  • 14:15
    Proffered Paper: Genome-Wide CRISPR Screening Identifies Lipid-Sensing Chemosensor Receptors as Regulators of Tumor-Associated Macrophage Function in Cancer
    EACR25-1932
    MarelliGiulia Presenter Italy
  • 14:30
    Proffered Paper: A novel spatial DNA sequencing method for the detection of somatic mutations from hundreds of regions in archival tissue sections
    EACR25-2439
    RaoRaoSrinivasa Presenter United Kingdom
  • 14:45
    Proffered Paper: Oncostatin M cytokine signalling orchestrates immune remodelling and metabolism within the breast tumour microenvironment
    EACR25-0851
    AzcoagaPeio Presenter Spain
  • 15:00
    Proffered Paper: 177Lu-Trastuzumab as a promising therapy for resistant brain metastases in HER2+ breast cancer
    EACR25-1471
    SantosLiliana Presenter Portugal
Auditorium I
OricchioElisa Co-Chair Switzerland
CohenMerav Co-Chair Israel
  • 14:00
    Introduction of the Mark Foundation
    BishRebecca Presenter United States
  • 14:05
    2025 EACR-Mark Foundation -Pezcoller Foundation Rising Star Award Lecture: Unravelling cell plasticity in tumor initiation and progression
    KovatchevaMarta Award Lecture Italy
  • 14:25
    Introduction AstraZeneca Fellowship and Award
    OricchioElisa Presenter Switzerland
  • 14:30
    EACR - AstraZeneca Postdoctoral Fellowship Award Lecture: Targeting immunosuppression induced by oncogenic PI3K/AKT signalling to enhance anti-tumour immunity in breast cancer
    van WeverwijkAntoinette Award Lecture The Netherlands
  • 14:50
    Introduction Boehringer Ingelheim Fellowship and Award
    HofmannMarco Presenter Austria
  • 14:55
    EACR - Boehringer Ingelheim Postdoctoral Fellowship Award Lecture: Implications of one carbon metabolism in cancer cell proliferation and metastasis
    KiwelerNicole Award Lecture Luxembourg
Auditorium II
RyanKevin Co-Chair United KingdomMolecular Oncology
BernardsRene Co-Chair Netherlands
  • 14:00
    DNA damage, cancer and aging and the unexpected impact of nutritional interventions
  • 14:25
    Multimodal, Generative, and Agentic AI for Pathology
    MahmoodFaisal Speaker United States
  • 14:50
    Decoding the Cancer Connectome of Brain Tumor Networks
    VenkataramaniVarun Speaker Germany
Auditorium VI+VII
15:15
15:45
Meet and Greet EACR Ambassador and Solo Travellers
EACR Stand
Coffee Break / Exhibition
Poster and Exhibition Hall
15:45
18:15
  • 15:45
    Opening Address
    SamuelsYardena Chair Israel
  • 15:47
    Welcome by the Mayor of Lisbon
    MoedasCarlos Presenter Portugal
  • 15:52
    Introduction of Keynote Speaker
    SamuelsYardena Chair Israel
  • 15:55
    Myeloid Mayhem: Inflammation driven Lung Cancer initiation and progression
    SwantonCharles Keynote Speaker United Kingdom
  • 16:40
    Pezcoller Award Presentation and Introduction of the Award Recipients
    GalligioniEnzo Presenter Italy
  • 16:45
    The Pezcoller Foundation-EACR Translational Cancer Researcher Award 2025 - Leveraging single cell technologies to engineer the immune system
    AmitIdo Award Lecture Israel
  • 17:30
    The Pezcoller-Marina Larcher Fogazzaro-EACR Women in Cancer Research Award 2025 - Dissecting Tumor-Immune Crosstalk in Cancer Progression and Therapy
    de VisserKarin E. Award Lecture Netherlands
Auditorium I
18:15
18:30
EACR General Assembly and Awards Ceremony (EACR Members only) (18:15 - 18:30)
Auditorium I
Welcome Reception (18:15 - 20:00)
Poster and Exhibition Hall
18:45
19:00
Stilla Technologies Industry Spotlight: Setting the stage for microRNA signatures in clinical practice – multiplexed microRNA analysis with digital PCR
TostJorg Industry Speaker France
Spotlight Theatre
19:15
19:30

Tuesday, 17 June 2025

Time Session
08:30
09:15
  • 08:30
    Introduction to the Invitrogen™ EVOS™ S1000 Spatial Imaging System
    GrespiFrancesca Industry Speaker
  • 08:35
    Spatial Proteomics: Transforming Our Understanding of Cancer Biology
    StadlerCharlotte Industry Speaker Sweden
  • 08:55
    Navigating Challenges in Spatial Proteomics from an Imaging Core facility perspective
    Carolina Oses Industry Speaker
  • 09:10
    Questions and Answers
Auditorium II
  • 08:30
    Experience Live Single-Cell Functional Insights with Beacon Discovery for Oncology & Immunotherapy Research
    SantosTiago Industry Speaker United States
    ZhangYan Industry Speaker United States
Auditorium VI+VII
LianidouEvi Moderator Greece
  • 08:30
    Multi-Omic Profiling for Precision Pediatric Cancer Diagnosis
    MardisElaine R. Speaker United States
  • 08:45
    TDiagnosis of MDS from peripheral blood
    ShlushLiran I. Speaker Israel
  • 09:00
    Discussion with the Experts
Career Discovery Area
09:20
10:55
CohenMerav Co-Chair Israel
SamuelsYardena Co-Chair Israel
  • 09:20
    Engineered dendritic cell therapy
    De PalmaMichele Speaker Switzerland
  • 09:45
    Proffered Paper: Synergistic effect of thiopurine 6TG and immunocheckpoint blockade to inhibit melanoma growth
    EACR25-0734
    De ZioDaniela Presenter Denmark
  • 09:55
    Exploiting immune surveillance to target colorectal cancer
    BardelliAlberto Speaker Italy
  • 10:20
    Proffered Paper: Systematic identification of recurrent immunogenic neoantigens in treatment-resistant tumors
    EACR25-2222
    GumpertNofar Presenter Israel
  • 10:30
    Translation Dysregulation In Cancer as a Source for Targetable Antigens
    SamuelsYardena Speaker Israel
Auditorium I
BaggioliniArianna Co-Chair Switzerland
JoyceJohanna A Co-Chair Switzerland
  • 09:20
    Identifying and targeting metabolic vulnerabilities in leptomeningeal metastasis
    BoireAdrienne Speaker United States
  • 09:45
    Proffered Paper: Reshaping Tumor-Vascular-Immune Crosstalk by VEGFR-3 Modulation in Breast Cancer Brain Metastases
    EACR25-1283
    MacelaCarolina Presenter Portugal
  • 09:55
    Strategies to challenge brain metastases in mice and human
    ValienteManuel Speaker Spain
  • 10:20
    Proffered Paper: Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3
    EACR25-1678
    SeehawerMarco Presenter United States
  • 10:30
    Unraveling the Complexity of Cancer Ecosystems
    JoyceJohanna A Speaker Switzerland
Auditorium II
EngCathy Co-Chair United States
dos Santos DiasMatheus Co-Chair The Netherlands
  • 09:20
    Genomic epidemiology approaches to elucidate the causes of Early onset colorectal cancer globally
    Perdomo VelasquezSandra Speaker France
  • 09:45
    Proffered Paper: Geographic and age-related variations in mutational processes in colorectal cancer
    EACR25-1102
    Díaz-GayMarcos Presenter Spain
  • 09:55
    More Than Mutations: A Survival Guide for Nascent Tumours
    AlcoleaMaria Pilar Speaker United Kingdom
  • 10:20
    Proffered Paper: Proffered Paper: Fibroblast specific endoglin deletion increases colorectal cancer tumorigenesis in a subset-specific manner
    EACR25-1472
    AbudukelimuSubinuer Presenter Netherlands
  • 10:30
    The burgeoning horizon of early-onset GI cancers
    EngCathy Speaker United States
Auditorium VI+VII
10:55
11:35
Coffee Break / Exhibition / Industry Spotlight
Poster and Exhibition Hall
11:15
11:30
JacquetMaxime Industry Speaker Netherlands
  • 11:15
    Empowering Cancer Research with Award-Winning Technologies from CST: SignalStar® Multiplex IHC and InTraSeqTM Single Cell Analysis
    JacquetMaxime Industry Speaker Netherlands
Spotlight Theatre
11:35
13:10
DiveCaroline Co-Chair United Kingdom
EscuderoLaura Co-Chair Canada
  • 11:35
    New Insights into the Impact of the Tumor Microbiome on Immunotherapy Response
    StrausmannRavid Speaker Israel
  • 12:00
    Proffered Paper: Epigenetic regulation shapes the tumor microenvironment in NSCLC and impacts the outcome of immune checkpoint blockade therapy
    EACR25-0504
    Gallardo-GómezMaría Presenter Spain
  • 12:10
    Optimal Outcome for High-risk Breast Cancer by Response Predictive Biomarkers
    Van't VeerLaura Speaker United States
  • 12:35
    Proffered Paper: Monitoring genetic and epigenetic evolution of metastatic colorectal cancer through longitudinal ctDNA profiling
    EACR25-0818
    chemifrancesca Presenter Italy
  • 12:45
    The Immune Contexture Concept and Clinical Utility
    GalonJerome Speaker France
Auditorium I
TrumppAndreas Co-Chair Germany
dos Santos DiasMatheus Co-Chair The Netherlands
  • 11:35
    Diagnosing the myeloid malignancy continuum from the peripheral blood
    ShlushLiran I. Speaker Israel
  • 12:10
    Clonal Hematopoiesis and Cancer
    BernardElsa Speaker France
  • 12:35
    Proffered Paper: Bulk and spatial B cell receptor repertoire analysis to characterize antibody maturation in relation to tertiary lymphoid structures and response to immunotherapy
    EACR25-2072
    PupierGuilhem Presenter France
  • 12:45
    Quantitative insights into somatic evolutionary dynamics in healthy and pre-malignant blood
    BlundellJamie Speaker United Kingdom
Auditorium II
JacquemetGuillaume Co-Chair Finland
ErezNeta Co-Chair Israel
  • 11:35
    Aging Stroma Drives Breast Cancer Progression
    StewartA.Sheila Speaker United States
  • 12:00
    Proffered Paper: Circulating tumor cells shed a new class of shearosome large extracellular vesicles in capillary bifurcations that drive metastatic processes
    EACR25-0080
    AuSam Presenter United Kingdom
  • 12:10
    Cancer – Matrix Crosstalk in Cancer Progression
    IvaskaJohanna Speaker Finland
  • 12:35
    Proffered Paper: Cockle transmissible cancers characterized by horizontal transfers and instability of mitogenomes
    EACR25-0182
    BRUZOSAlicia L. Presenter France
  • 12:45
    Targeting the metastatic microenvironment
    IsackeClare Speaker United Kingdom
Auditorium VI+VII
VallotCeline Co-Chair France
SflomosGeorgios Co-Chair Switzerland
  • 11:35
    Mechanisms of cell plasticity in breast cancer
    VallotCeline Speaker France
  • 12:00
    Proffered Paper: Transcriptional state transitions link tissue injury and early carcinogenesis in the kidney
    EACR25-0509
    HirosueShoko Presenter United Kingdom
  • 12:10
    Targeting lineage plasticity in castration resistant prostate cancer
    KarthausWouter Speaker Switzerland
  • 12:35
    Proffered Paper: SpliceSeek: a CRISPR-based platform for uncovering T-cell alternative splicing isoforms for immunotherapy
    EACR25-1366
    TzabanShay Presenter Israel
  • 12:45
    Tissue-specific transcriptional vulnerabilities in cancer
    VanharantaSakari Speaker Finland
Auditorium VIII
13:15
15:15
Lunch Break / Exhibition / Poster Viewing
Poster and Exhibition Hall
13:30
14:15
BabayanAnna Industry Moderator/ Chair Germany
  • 13:30
    Introduction to multiomics
    BabayanAnna Industry Moderator/ Chair Germany
  • 13:35
    Rapid WGS with Constellation read map technology for paediatric cancer research
    VediAditi Industry Speaker United Kingdom
  • 13:50
    Identification of biomarkers for early detection of colorectal cancer: multiomic, epigenetic and metagenomic analysis of rectal mucus sampling
    WiseDaniel Industry Speaker United Kingdom
  • 14:05
    BreakThrough Spotlight – Early Career Researcher Unravelling Tumour Genetics: The Role of cfDNA Whole-Exome Sequencing in Treatment Response Assessment
    SerioViola Bianca Industry Speaker Italy
  • 14:10
    Q&A and panel discussion
Auditorium II
SchalénMartin Industry Moderator/ Chair Sweden
  • 13:30
    Characterization of a novel cancer-associated fibroblast population with immunosuppressive functions
    WittwerAlina Industry Speaker Germany
  • 13:50
    Multiplexed Imaging-Powered Deep Visual Proteomics (mipDVP)
    ZhengXiang Industry Speaker Denmark
  • 14:10
    Questions and Answers
Auditorium VI+VII
BianchiMarco Giorgio Industry Moderator/ Chair Italy
  • 13:30
    Introduction
    BianchiMarco Giorgio Industry Moderator/ Chair Italy
  • 13:35
    Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer
    Muinelo RomayLaura Industry Speaker Spain
  • 13:50
    Detection rate for ESR1 mutations is higher in CTC-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCR
    NtzifaAliki Industry Speaker Greece
  • 14:05
    Questions and Answers
Auditorium VIII
(open to EACR Early Career & Student Members, pre-registration required)
  • 13:30
    Details to be announced in 2025
Career Discovery Area
14:25
15:15
(open to EACR Early Career & Student Members, pre-registration required)
CarracedoArkaitz Coordinator Spain
OricchioElisa Coordinator Switzerland
  • 14:25
    TABLE 1: Efficient and caring mentorship: how to make your research team flourish?
    JoyceJohanna A Moderator Switzerland
  • 14:25
    TABLE 2: Leadership: Experience of a former EACR president
    DiveCaroline Moderator United Kingdom
  • 14:25
    TABLE 3: Building Equitable Research Careers for Women
    IvaskaJohanna Moderator Finland
  • 14:25
    TABLE 4: How to make your research transferable to the clinic
    ValienteManuel Moderator Spain
  • 14:25
    TABLE 5: How to effectively lead a large research group and handle leadership responsibilities
    SamuelsYardena Moderator Israel
  • 14:25
    TABLE 6: Challenges of starting a new lab and becoming a PI abroad
    AlcoleaMaria Pilar Moderator United Kingdom
  • 14:25
    TABLE 7: Experience of creating a biomedical start-up in parallel to leading a research team
    VallotCeline Moderator France
  • 14:25
    TABLE 8: The challenges of opening your own lab
    KarthausWouter Moderator Switzerland
  • 14:25
    TABLE 9: ERC funding opportunities for starting or establishing a research group in the EU or Associated Countries
    Veronica Caraffini Moderator
  • 14:25
    TABLE 10: Lessons from My Journey: Navigating Data Science & Bioinformatics Careers in Pharma
    SinaNassiri Moderator Switzerland
Career Discovery Area
14:30
15:15
  • 14:30
    One platform and endless possibilities for immuno-oncology research
    KowalJoanna Industry Speaker Switzerland
  • 14:45
    Exploring the Spatial Biology of Colorectal Cancer Liver Metastases
    Xenia MariaFicht Industry Speaker Switzerland
Auditorium II
ScheidLisa-Mareike Industry Moderator/ Chair Germany
  • 14:30
    Introduction by Moderator
    ScheidLisa-Mareike Industry Moderator/ Chair Germany
  • 14:35
    How to kill your fibroblasts and save the cancer stem cells in your culture
    TrampeAlexander Industry Speaker Germany
  • 15:00
    PromoCell’s Cancer Media Toolbox
    TrampeAlexander Industry Speaker Germany
  • 15:05
    Questions & Answers
Auditorium VI+VII
CelisSebastian Industry Moderator/ Chair United States
  • 14:30
    Leveraging high dimensional multiomic screens with AVITI24™ to accelerate drug discovery
    NelIvonne Industry Speaker Germany
Auditorium VIII
15:20
16:55
SflomosGeorgios Co-Chair Switzerland
ErezNeta Co-Chair Israel
  • 15:20
    Charting the intact breast tumour microenvironment
    AliRaza Speaker United Kingdom
  • 15:45
    Proffered Paper: Characterization of a population of CD4⁻ CD8⁻ Double-Negative T Cells with anti-tumor properties
    EACR25-1514
    Di CeglieIrene Presenter Italy
  • 15:55
    Stromal and immune plasticity shape the metastatic microenvironment
    ErezNeta Speaker Israel
  • 16:20
    Proffered Paper: Rewiring T Cell Networks to Overcome Immune Evasion in Ovarian Cancer Relapse
    EACR25-2250
    DANGAJ LANITIDENARDA Presenter Switzerland
  • 16:30
    The Power of ONE: Immunology in the Age of Spatial and Single-Cell Genomics
    AmitIdo Speaker Israel
Auditorium I
TrumppAndreas Co-Chair Germany
dos Santos DiasMatheus Co-Chair The Netherlands
  • 15:20
    Harnessing senescence biology for immune oncology (REMOTE Presentation)
    LoweScott Speaker United States
  • 15:45
    Proffered Paper: Targeting senescent macrophages inhibits metastatic dissemination in adrenocortical cancer
    EACR25-0260
    ValPierre Presenter France
  • 15:55
    Controlling therapy-induced senescence: novel approaches to senolysis
    KovatchevaMarta Speaker Italy
  • 16:20
    Proffered Paper: Therapy-Induced Senescence Promotes Immunogenicity in Acute Myeloid Leukemia Blasts through loss of PRC2-Mediated Regulation
    EACR25-0844
    FuscoSimona Presenter Italy
  • 16:30
    Plasticity of Leukemic Stem Cells
    TrumppAndreas Speaker Germany
Auditorium II
MouliereFlorent Co-Chair United Kingdom
EscuderoLaura Co-Chair Canada
  • 15:20
    Detection of Cancer with Liquid Biopsy
    PapadopoulosNickolas Speaker United States
  • 15:45
    Towards multi-modal liquid biopsies
    MouliereFlorent Speaker United Kingdom
  • 15:45
    Proffered Paper: Unravelling Principles of Adaptive Chemoresistance through Dynamic Transcriptional Patterns in Individual Breast Cancer Patients
    EACR25-0255
    MayaDadiani Presenter Israel
  • 16:10
    Proffered Paper: KRAS pharmacological blockade elicits tumoral homologous recombination deficiency exploitable with PARP inhibitors
    EACR25-0812
    VicentSilvestre Presenter Spain
  • 16:20
    A DNA methylation atlas of normal human cell types
    KaplanTommy Speaker Israel
Auditorium VI+VII
CarracedoArkaitz Co-Chair Spain
ErezAyelet Co-Chair Israel
  • 15:20
    Modeling cachexia in mice: from intestinal cancer models to distinct host trajectories
    PennaFabio Speaker Italy
  • 15:45
    Proffered Paper: Oncolytic virus (CVA21) in combination with pembrolizumab increases tumour cell immunogenicity and remodels the tumour microenvironment in advanced NSCLC: a phase I/II trial
    EACR25-1995
    BalasubramanianAdithya Presenter Australia
  • 15:55
    Insights into cancer cachexia from the TRACERx lung cancer study
    Jamal-HanjaniMariam Speaker United Kingdom
  • 16:20
    Proffered Paper: Translational control shapes Treg cell fate in the tumor microenvironment
    EACR25-2124
    OlivetoStefania Presenter Italy
  • 16:30
    Exploring the tumor MACROenvironment for improving cancer diagnosis and therapy
    ErezAyelet Speaker Israel
Auditorium VIII
16:55
17:30
Coffee Break / Exhibition / Industry Spotlight
Poster and Exhibition Hall
17:15
17:30
ScocchiaDanniela Industry Speaker Spain
  • 17:15
    Redefining Single Cell RNA Sequencing Limits with Evercode Combinatorial Barcoding
    As single cell technologies have advanced, assay scalability has become a critical factor in capturing the full heterogeneity and complexity of biological systems. With its combinatorial barcoding platform, Evercode, Parse continues to redefine the limits of single cell research. Join us for our spotlight presentation to learn about the latest updates to Evercode, including the launch of Evercode WT Penta, for profiling of up to 5 million cells and up to 384 samples in a single run.
    ScocchiaDanniela Industry Speaker Spain
Spotlight Theatre
17:30
18:15
BardelliAlberto Chair Italy
  • 17:30
    Cancer Metabolism
    WhiteEileen Keynote Speaker United States
Auditorium I
18:15
18:40
  • 18:15
    Fishing for new immunotherapy compounds to boost innate-tumor rejection (EACR25-0448)
    P-450
    MachadoBeatrizAna Presenter Portugal
  • 18:15
    Ovarian cancer Zebrafish Avatars for personalized multiple drug testing (EACR25-0644)
    P-553
    EstradaFalcãoMarta Presenter Portugal
  • 18:15
    Senescence Induction Sensitizes Hepatocellular Carcinoma Cells to Immunotherapy (EACR25-1308)
    P-156
    MaXuhui Presenter China
  • 18:15
    Longitudinal Dynamics of Transcriptome and Chromatin Accessibility in Ovarian High‐Grade Serous Carcinoma (EACR25-1912)
    P-730
    AfentevaDaria Presenter Finland
  • 18:15
    Neutrophil serine proteases alter IL-18 to a superkine (EACR25-2188)
    P-479
    WöhrAnne Presenter Sweden
Spotlight Theatre
18:40
20:00
10:45
20:00
Poster and Exhibition Hall
Poster and Exhibition Hall

Wednesday, 18 June 2025

Time Session
08:30
09:15
HardcastleTravis Industry Moderator/ Chair United States
  • 08:30
    Introduction
    HardcastleTravis Industry Moderator/ Chair United States
  • 08:35
    Unveiling SURF2’sRole in Nucleolar Stress and Its Potential as a Therapeutic Target
    LebaronSimon Industry Speaker France
  • 08:50
    AI-driven identification and validation of novel synthetic lethal gene pairs
    MillerDaniel Industry Speaker United Kingdom
  • 09:05
    Leveraging an advanced CRISPR platform to streamline oncology breakthroughs
    SoenensAmalia Industry Speaker
Auditorium II
  • 08:30
    Transposable elements reorganise the 3D genome structure in CDK4/6 inhibitors resistant breast cancer.
    Achinger-KaweckaJoanna Industry Speaker Australia
Auditorium VI+VII
TrumppAndreas Moderator Germany
  • 08:30
    Advancing Science Through Industry-Academic Collaboration: Pre-Clinical Development of KRAS Modulators
    HofmannMarco Speaker Austria
  • 08:45
    Tumor Archetypes Reimagined: Multi-Omic Insights, AI-Driven Discovery, and New Frontiers in Cancer Subtyping
    SinaNassiri Speaker Switzerland
  • 09:00
    Discussion with the Experts
Career Discovery Area
09:20
10:55
WestermarckJukka Co-Chair Finland
CaffarelMaria M. Co-Chair Spain
  • 09:20
    Drugging transcription factors: HSF1 and Brachyury
    WorkmanPaul Speaker United Kingdom
  • 09:45
    Proffered Paper: Inhibition of WEE1 kinase activity to overcome secondary resistance to targeted therapies in colorectal cancer
    EACR25-0376
    ArenaSabrina Presenter Italy
  • 09:55
    Targeting chromatin proteins for therapeutic benefit in haematological malignancy
    SomervailleTim Speaker United Kingdom
  • 10:20
    Proffered Paper: Reversing Acidic Immune Suppression in Cancer with PTT-4256, A First-In-Class Small Molecule Inhibitor of GPR65
    EACR25-0553
    CorbinAlastair Presenter United Kingdom
  • 10:30
    PP2A inhibitor protein CIP2A is a prime target for TNBC therapy
    WestermarckJukka Speaker Finland
Auditorium I
BaggioliniArianna Co-Chair Switzerland
WinklerFrank Co-Chair Germany
  • 09:20
    The neural regulation of small cell lung cancer progression
    VenkateshHumsa Speaker United States
  • 09:45
    Proffered Paper: Medullary sinus macrophages limit cancer therapy efficacy by an efferocytosis-induced IL-33/ST2 axis in the tumor-draining lymph node.
    EACR25-1319
    LamorteSara Presenter Canada
  • 09:55
    Neural mechanisms of brain tumor growth and resistance
    WinklerFrank Speaker Germany
  • 10:20
    Proffered Paper: Spatially Resolved Analysis of Cancer-Infiltrated Nerves Identifies DRAXIN as a Marker of Injury Response with Tumor-Suppressive Potential
    EACR25-1355
    OzgaJoannaAleksandra Presenter Switzerland
  • 10:30
    Neural-tumour communication accelerates cancer progression and impairs treatment response
    SloanErica Speaker Australia
Auditorium II
SalvadorBeatriz Co-Chair United Kingdom
RisquesRosana Co-Chair United States
  • 09:20
    Clonal evolution of cancer from initiation to metastasis in the mouse (REMOTE Presentation)
    BalmainAllan Speaker United States
  • 09:45
    Proffered Paper: Pancreatic Cancer Initiation: Wnt Signalling and Cell Dormancy Enable Kras Mutant Cell Survival
    EACR25-0647
    SalvadorBeatriz Presenter United Kingdom
  • 09:55
    Mutational landscape and clonal dynamics in normal and precancerous tissues
    RahbariRaheleh Speaker United Kingdom
  • 10:20
    Proffered Paper: Dietary Histidine controls intestinal stem cell activity, providing a potential protective role against colorectal cancer
    EACR25-0457
    BiehlerCornélia Presenter Finland
  • 10:30
    Somatic evolution in normal tissues and cancer risk
    RisquesRosana Speaker United States
Auditorium VI+VII
10:55
11:35
Coffee Break / Exhibition/ Industry Spotlight
Poster and Exhibition Hall
11:15
11:30
VettoreNicola Industry Speaker Germany
  • 11:15
    Label-free spheroids and organoids analysis for assays development
    VettoreNicola Industry Speaker Germany
Spotlight Theatre
11:35
13:10
CaldasCarlos Co-Chair United Kingdom
  • 11:35
    Epigenetic dysregulation and cancer evolution
    ScaffidiPaola Speaker Italy
  • 12:00
    Proffered Paper: Integrative multi-omic approach to identify patterns of immune selection in primary breast tumours
    EACR25-0508
    MonterdeBeatriz Presenter United Kingdom
  • 12:10
    EMBO Young Investigator Lecture: Cancer aneuploidy - From evolutionary pressures to cellular vulnerabilities
    Ben-DavidUri Speaker Israel
  • 12:35
    Proffered Paper: Genetic background sets the trajectory of cancer evolution
    EACR25-2424
    AitkenJSarah Presenter United States
  • 12:45
    Title to be announced
    TurajlicSamra Speaker United Kingdom
Auditorium I
ChumduriCindrilla Co-Chair Denmark
BernardsRene Co-Chair Netherlands
  • 11:35
    Cell plasticity in human colon and cancer
    SnippertHugo Speaker Netherlands
  • 12:00
    Proffered Paper: Contact-based transfer of thymidylate promotes collective tumor growth
    EACR25-0343
    SiddiquiMohammad Aarif Presenter Denmark
  • 12:10
    Development of advanced immunotherapies using human 3D-bioprinted cancer avatars
    Satchi-FainaroRonit Speaker Israel
  • 12:35
    Proffered Paper: Deconvolution of heterogeneous 3D mammary spheroid dynamics using Oblique Plane Microscopy (OPM)
    EACR25-2342
    ModerauNina Presenter United Kingdom
  • 12:45
    Deciphering the role of infection and diet in driving early carcinogenic events using advanced organoid models and omics
    ChumduriCindrilla Speaker Denmark
Auditorium II
AmbrogioChiara Co-Chair Italy
ParedesJoana Co-Chair Portugal
  • 11:35
    Studying melanoma therapy resistance one cell at the time
    MarineJean-Christophe Speaker Belgium
  • 12:00
    Proffered Paper: Dynamics and chemotherapy response of single cell-derived human breast cancer clones
    EACR25-0507
    KronheimRachaelSarah Presenter Canada
  • 12:10
    The role of RANK signaling in breast cancer biology and response to therapy
    CasimiroSandra Speaker Portugal
  • 12:35
    Proffered Paper: Unveiling the impact of intratumoral microbiota in the treatment efficacy of soft tissue sarcoma
    EACR25-0716
    TiraboschuiLuca Presenter Italy
  • 12:45
    Mechanism of response and resistance to RAS inhibition in solid tumors
    MisaleSandra Speaker United States
Auditorium VI+VII
BoitorAlexandra Co-Chair United Kingdom
Luisa CorreiaAna Co-Chair Portugal
  • 11:35
    Unravelling mechanisms of ER+ Breast cancer dormancy
    GomisRoger Speaker Spain
  • 12:00
    Proffered Paper: Translational Reprogramming Drives Immune Evasion in Melanoma Persister Cells Through MIF Secretion
    EACR25-2481
    SoumoyLaura Presenter France
  • 12:10
    What makes a tissue favorable or not to metastasis?
    Luisa CorreiaAna Speaker Portugal
  • 12:35
    Proffered Paper: Neuroblastoma metastatic cells adopt an embryonic diapause-like state in the fetal bone marrow driven by mTOR activity
    EACR25-0988
    Castillo FerrerCamila Presenter France
  • 12:45
    How host niche variations regulate disseminated cancer cell dormancy and awakening
    Aguirre-GhisoJulio A. Speaker United States
Auditorium VIII
13:15
15:15
Lunch Break / Exhibition / Poster Viewing
Poster and Exhibition Hall
13:30
14:15
Auditorium II
  • 13:30
    Introducing Illumina Single Cell and Spatial Technology
    MishraVivek Kumar Industry Moderator/ Chair Germany
  • 13:35
    Scalable single-cell RNA profiling of pooled CRISPR screens discloses novel biology of cancer and T cells
    Van MinselPaulien Industry Speaker Belgium
  • 13:50
    Cell Altasing Human Intestine using Illumina Spatial Technology
    ZhuChenchen Industry Speaker United States
  • 14:05
    Illumina Connected Multiomics
    ScmidJoachim Industry Speaker Germany
Auditorium VI+VII
  • 13:30
    TCR Repertoires of Tumor-Infiltrating γδ1 T Cells Reveal PD-1–Modulated Reactivity
    MikulakJoanna Industry Speaker Italy
Auditorium VIII
13:30
14:15
(open to EACR Early Career & Student Members, pre-registration required)
CarracedoArkaitz Coordinator Spain
OricchioElisa Coordinator Switzerland
  • 13:30
    TABLE 1: How to build your own network
    RisquesRosana Moderator United States
  • 13:30
    TABLE 2: Leadership: Experience in combining research with the direction of a research institute
    BardelliAlberto Moderator Italy
  • 13:30
    TABLE 3: Leadership: Experience as a team leader and a research center science director
    MarineJean-Christophe Moderator Belgium
  • 13:30
    TABLE 4: Life of a scientist between research and hospital
    SomervailleTim Moderator United Kingdom
  • 13:30
    TABLE 5: How to make your research impactful and transferable to the clinic
    GomisRoger Moderator Spain
  • 13:30
    TABLE 6: How to build a successful lab environment
    WestermarckJukka Moderator Finland
  • 13:30
    TABLE 7: How do you know when you are ready to start your own lab?
    TurajlicSamra Moderator United Kingdom
  • 13:30
    TABLE 8: Challenges of setting up a new lab and establishing yourself as a PI in your home country after years abroad
    Luisa CorreiaAna Moderator Portugal
  • 13:30
    TABLE 9: The challenges of starting your own lab
    VenkateshHumsa Moderator United States
  • 13:30
    TABLE 10: ERC funding opportunities for starting or establishing a research group in the EU or Associated Countries
    Veronica Caraffini Moderator
Career Discovery Area
14:25
15:15
(open to EACR Early Career & Student Members, pre-registration required)
CarracedoArkaitz Coordinator Spain
OricchioElisa Coordinator Switzerland
  • 14:25
    TABLE 1: A career at the intersection between cell biology and oncology
    RegenbergBirgitte Moderator Denmark
  • 14:25
    TABLE 2: Navigating a career in Academia and Industry
    PaganiMassimiliano Moderator Italy
  • 14:25
    TABLE 3: Challenges of being a clinician scientist: Successfully balancing clinical and academic duties
    TaberneroJosep Moderator Spain
  • 14:25
    TABLE 4: From fundamental science to translational impact
    DiazLuis Alberto Moderator United States
  • 14:25
    TABLE 5: A career in computational biology
    AranDvir Moderator Israel
  • 14:25
    TABLE 6: Challenges of establishing your lab in an unstable socio-political climate
    Ben-DavidUri Moderator Israel
  • 14:25
    TABLE 7: Current challenges in academia: tips to survive
    Aguirre-GhisoJulio A. Moderator United States
  • 14:25
    TABLE 8: The challenges of starting your own lab
    MisaleSandra Moderator United States
  • 14:25
    TABLE 9: Leadership: Experience of a former EACR president
    BernardsRene Moderator Netherlands
  • 14:25
    TABLE 10: From performing research to supporting researchers: transitioning from academia to scientific administration
    Veronica Caraffini Moderator
Career Discovery Area
14:30
15:15
RUCEVICGuyonnetMarijana Industry Moderator/ Chair Sweden
  • 14:30
    Olink Proteomics: Accelerating progress in cancer research and the path to therapeutics
    RUCEVICGuyonnetMarijana Industry Speaker Sweden
  • 14:40
    Deep plasma proteomics identifies and validates an eight-protein biomarker panel for ovarian cancer
    EnrothStefan Industry Speaker Sweden
  • 14:55
    Liquid biopsy: Plasma proteomics to identify novel biomarkers
    ItalianoAntoine Industry Speaker France
  • 15:10
    Questions and Answers
Auditorium II
  • 14:30
    Introduction to C13 Hyperpolarization
    BennettSimon Industry Speaker Germany
  • 14:40
    Applications for imaging and measuring metabolism in vivo
    BennettSimon Industry Speaker Germany
  • 15:10
    Q&A
Auditorium VI+VII
Juarez Eleonora Industry Moderator/ Chair United States
  • 14:30
    Unlocking Novel Cancer Biology with Multiomic Insights, Introduction by Chair/ Moderator
    Juarez Eleonora Industry Moderator/ Chair United States
  • 14:35
    Bridging genotype and phenotype through single-cell and single-molecule multi-omics
    HarbersLuuk Industry Speaker Belgium
  • 14:55
    Tumour heterogeneity and clonal selection of ecDNA at single-cell level
    Deleuran Hendriksen Josephine Industry Speaker Denmark
Auditorium VIII
15:20
16:55
CaldasCarlos Co-Chair United Kingdom
JacquemetGuillaume Co-Chair Finland
  • 15:20
    Agent-Based Modelling of Gene Networks the tumour microenvironment ecosytem
    BuffaMeteoraFrancesca Speaker United Kingdom
  • 15:45
    Proffered Paper: High-throughput drug screening in breast cancer PDTCs enables clinically relevant drug discovery for personalised medicine.
    EACR25-1681
    MasinaRiccardo Presenter United Kingdom
  • 15:55
    The power of many: Unlocking treatment response patterns through single-cell meta-analysis
    AranDvir Speaker Israel
  • 16:20
    Proffered Paper: Spatial and multi-omic profiling of HGSC to identify immune vulnerabilities for precision immunotherapy
    EACR25-0439
    ShabanovaAleksandra Presenter Finland
  • 16:30
    Title to be announced
    McGranahanNicholas - Speaker (TBI) United Kingdom
Auditorium I
LimEmilia Co-Chair Canada
SoengasMarisol S. Co-Chair Spain
  • 15:20
    Polygenic risk models and prevention in breast and ovarian cancer
    PharoahPaul Speaker United States
  • 15:45
    Proffered Paper: Multi-omic spatial analysis reveals reshaping of tumour-immune dynamics at the transition to invasive colorectal cancer
    EACR25-1604
    BakerAnn-Marie Presenter United Kingdom
  • 15:55
    Mechanisms of Lung Cancer Promotion
    HillWilliam Speaker United Kingdom
  • 16:20
    Proffered Paper: Tumour genotype shapes blood biomarker expression for use in pancreatic cancer detection and diagnosis
    EACR25-0817
    CanelMarta Presenter United Kingdom
  • 16:30
    Investigating the impact of environmental exposures
    LimEmilia Speaker Canada
Auditorium II
BardelliAlberto Co-Chair Italy
DiazLuis Alberto Co-Chair United States
  • 15:20
    DNA repair-dependent immunogenic liabilities in colorectal cancer: the opportunity comes from the errors
    GermanoGiovanni Speaker Italy
  • 15:45
    Proffered Paper: Exploit Neutrophil Heterogeneity to induce Synthetic Lethality in Breast Cancer
    EACR25-0256
    CalcinottoArianna Presenter Switzerland
  • 15:55
    Immunoprevention in Lynch Syndrome
    DiazLuis Alberto Speaker United States
  • 16:20
    Proffered Paper: Intratumoral STING pathway activation enhances anti-tumor immune responses and therapeutic efficacy of ATR inhibition.
    EACR25-0468
    SenTriparna Presenter United States
  • 16:30
    Title to be announced
    PaganiMassimiliano Speaker Italy
Auditorium VI+VII
DiveCaroline Co-Chair United Kingdom
dos Santos DiasMatheus Co-Chair The Netherlands
  • 15:20
    Extrachromosomal DNA (ecDNA): Cancer’s Dynamic Circular Genome
    MischelPaul Salomon Speaker United States
  • 15:45
    Proffered Paper: Heterogeneous oncogene dosage driven by extrachromosomal DNA determines neuroblastoma response to therapy
    EACR25-0364
    MontuoriGiulia Presenter Germany
  • 15:55
    Functional Role of Extrachromosomal Circular DNA in Colorectal, Renal and Bladder Cancers
    RegenbergBirgitte Speaker Denmark
  • 16:20
    Proffered Paper: Investigating the impact of extrachromosomal DNA amplification on cell fate decisions and therapy resistance
    EACR25-2262
    RachelSchmargon Presenter Germany
  • 16:30
    A general strategy to model ecDNA-mediated focal amplifications in cells and in mice
    VenturaAndrea Speaker
Auditorium VIII
16:55
18:30
Coffee Break / Exhibition / Industry Spotlight
Poster and Exhibition Hall
17:15
17:30
ChenchikAlex Industry Speaker United States
  • 17:15
    A practical guide for adaptive immune receptor repertoire profiling and the characterization of antigen-induced clonotypes with applications in cancer, vaccine development, and autoimmunity
    ChenchikAlex Industry Speaker United States
Spotlight Theatre
17:30
18:15
BardelliAlberto Chair Italy
BernardsRene Co-Chair Netherlands
Auditorium I
18:15
18:40
  • 18:15
    Dissecting ovarian cancer cellular responses to radioimmunotherapy with β- particle and ultra-short range conversion and Auger electron-emitting radionuclides. (EACR25-0133)
    P-552
    GrzmilMichal Presenter Switzerland
  • 18:15
    Pan-cancer analysis of successive whole genome duplication in the 100,000 Genomes Project (EACR25-0555)
    P-746
    SmythEvie Presenter Ireland
  • 18:15
    COX-2/PGE2 Activity in Cancer Cells: A Key Driver of Metastasis via Immune Escape (EACR25-0743)
    P-773
    RussoMassimo Presenter United Kingdom
  • 18:15
    Depleting tumour-infiltrating Tregs to enhance the efficacy of KRAS-mutant targeted therapies in lung cancer (EACR25-1513)
    P-790
    de CastroAndrea Presenter United Kingdom
  • 18:15
    Cytotoxic ILC-1 cells determine outcome of PD-(L)1 blockade in microsatellite instable cancers (EACR25-2039)
    P-522
    Van RoyenPaula Presenter Netherlands
Spotlight Theatre
18:40
20:00
Poster Defence Session - Wednesday
10:45
20:00
Poster and Exhibition Hall
Poster and Exhibition Hall

Thursday, 19 June 2025

Time Session
09:00
09:15
SamuelsYardena Co-Chair Israel
  • 09:00
    Align, Act, Accelerate – the future of European Research (REMOTE Presentation)
    HeitorManuel Speaker Portugal
Auditorium I
09:15
10:00
JoyceJohanna A Chair Switzerland
  • 09:15
    The Role of Plasticity in Tissue Remodeling and Tumor Progression
    Pe\'erDana Keynote Speaker United States
Auditorium I
10:00
11:15
BardelliAlberto Moderator Italy
DiveCaroline Moderator United Kingdom
Auditorium I
11:15
11:30
Coffee Break
Main Foyer
11:30
12:15
BernardsRene Chair Netherlands
  • 11:30
    Uncovering and targeting the mechanisms regulating tumor plasticity
    BlanpainCedric Keynote Speaker Belgium
Auditorium I
12:15
12:20
Break
Main Foyer
12:20
13:10
SamuelsYardena Chair Israel
  • 12:20
    ‘The EMBO Keynote Lecture’: Modelling breast cancers in space and time
    CaldasCarlos Keynote Speaker United Kingdom
  • 13:05
    EACR 2025 - Closing Remarks
    SamuelsYardena Chair Israel
Auditorium I